However, various studies have produced contradictory results concerning the development of pancreatic cancer; namely, some suggest the development of pancreatic cancer in T2D individuals who are treated with GLP-1RA, as opposed to those who are treated with insulin. This evidence concerns the gene INS and pancreatic neoplasm.